InvestorsHub Logo
Followers 167
Posts 35823
Boards Moderated 3
Alias Born 10/20/2019

Re: WallStreetSurvivor post# 105

Wednesday, 05/19/2021 11:35:48 AM

Wednesday, May 19, 2021 11:35:48 AM

Post# of 123
$EMOR is very undervalued!

"we believe EMOR should be trading at $2.8-$3.3 per share vs the prevailing $1.20. Acknowledging that Healixa is in the very early stages of commercializing its virtual care ecosystem, we place a Speculative Buy recommendation on the stock, but put it on watch to a possible upgrade to a firm BUY as we monitor the company’s early operational progress, moves towards a main board uplisting...”